200 related articles for article (PubMed ID: 10721069)
21. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.
Hirsch LJ; Weintraub D; Du Y; Buchsbaum R; Spencer HT; Hager M; Straka T; Bazil CW; Adams DJ; Resor SR; Morrell MJ
Neurology; 2004 Sep; 63(6):1022-6. PubMed ID: 15452293
[TBL] [Abstract][Full Text] [Related]
22. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
[TBL] [Abstract][Full Text] [Related]
23. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
24. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
[TBL] [Abstract][Full Text] [Related]
25. An investigation of the influence of patient-related factors and comedications on lamotrigine clearance in patients with epilepsy.
Baldoni AO; Freitas-Lima P; de Santi Ferreira FI; Martinez EZ; Queiroz RH; Sakamoto AC; Alexandre V; Perucca E; Pereira LR
Clin Exp Pharmacol Physiol; 2016 Jul; 43(7):685-9. PubMed ID: 27120710
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological outcomes in newly diagnosed epilepsy.
Mohanraj R; Brodie MJ
Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
[TBL] [Abstract][Full Text] [Related]
27. Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine.
Svalheim S; Mushtaq U; Mochol M; Luef G; Rauchenzauner M; Frøland SS; Taubøll E
Acta Neurol Scand Suppl; 2013; (196):11-5. PubMed ID: 23190286
[TBL] [Abstract][Full Text] [Related]
28. Lamotrigine in treatment of 120 children with epilepsy.
Schlumberger E; Chavez F; Palacios L; Rey E; Pajot N; Dulac O
Epilepsia; 1994; 35(2):359-67. PubMed ID: 8156958
[TBL] [Abstract][Full Text] [Related]
29. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
[TBL] [Abstract][Full Text] [Related]
30. How to replace lamotrigine with valproate.
Steinhoff BJ
Epilepsia; 2006 Nov; 47(11):1943-4. PubMed ID: 17116036
[TBL] [Abstract][Full Text] [Related]
31. [Lamotrigine: first experience in Italy].
de Romanis F; Sopranzi N
Clin Ter; 1995 Mar; 146(3):203-9. PubMed ID: 7789082
[TBL] [Abstract][Full Text] [Related]
32. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.
Reunanen M; Dam M; Yuen AW
Epilepsy Res; 1996 Mar; 23(2):149-55. PubMed ID: 8964276
[TBL] [Abstract][Full Text] [Related]
33. Combination vigabatrin and lamotrigine therapy for intractable epilepsy.
Schapel GJ; Black AB; Lam EL; Robinson M; Dollman WB
Seizure; 1996 Mar; 5(1):51-6. PubMed ID: 8777553
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
[TBL] [Abstract][Full Text] [Related]
35. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
Moeller JJ; Rahey SR; Sadler RM
Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
[TBL] [Abstract][Full Text] [Related]
36. A cost-effectiveness decision model for antiepileptic drug treatment in newly diagnosed epilepsy patients.
Knoester PD; Deckers CL; Termeer EH; Boendermaker AJ; Kotsopoulos IA; de Krom MC; Keyser T; Renier WO; Hekster YA; Severens HL
Value Health; 2007; 10(3):173-82. PubMed ID: 17532810
[TBL] [Abstract][Full Text] [Related]
37. No increase in carbamazepine-10,11-epoxide during addition of lamotrigine treatment in children.
Eriksson AS; Boreus LO
Ther Drug Monit; 1997 Oct; 19(5):499-501. PubMed ID: 9357090
[TBL] [Abstract][Full Text] [Related]
38. Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents.
Mazurkiewicz-Bełdzińska M; Szmuda M; Matheisel A
Seizure; 2010 Apr; 19(3):195-7. PubMed ID: 20167512
[TBL] [Abstract][Full Text] [Related]
39. Lack of an effect of topiramate on lamotrigine serum concentrations.
Berry DJ; Besag FM; Pool F; Natarajan J; Doose D
Epilepsia; 2002 Aug; 43(8):818-23. PubMed ID: 12180999
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study.
Eriksson AS; Nergårdh A; Hoppu K
Epilepsia; 1998 May; 39(5):495-501. PubMed ID: 9596201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
